These results indicate the treatment may be inducing an increase in the expression of FASL by B‐cells and that higher expression is associated with reversion back to healthy (or latently infected state) status, as the data show that B‐cells from healthy controls has a higher expression of FASL compared to TB cases at diagnosis. The gene discussed is FASLG; the disease is tuberculosis.